ERD-308

Catalog No. A18446

ERD-308 is a highly potent PROTAC degrader of estrogen receptor (ER) for ER positive breast cancer treatment.
Catalog Num A18446
M. Wt 1004.26
Formula C55H65N5O9S2
Purity >98%
Storage at -20 °C 3 years (powder form); at -20 °C 6 months (Solution base)
CAS No. 2320561-35-9
Synonyms ERD308, ERD 308
SMILES O=C(C1=C(C2=CC=C(O)C=C2)SC3=CC(O)=CC=C13)C4=CC=C(OCCN(CCCCCOCC(N[[email protected]@H](C(C)(C)C)C(N5[[email protected]](C(N[[email protected]@H](C)C6=CC=C(C7=C(C)N=CS7)C=C6)=O)C[[email protected]@H](O)C5)=O)=O)CC)C=C4
ERD-308 is a highly potent PROTAC degrader of estrogen receptor (ER) for ER positive breast cancer treatment.
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
0.1 mM 9.96 mL 49.79 mL 99.58 mL
0.5 mM 1.99 mL 9.96 mL 19.92 mL
1 mM 1 mL 4.98 mL 9.96 mL
5 mM 0.2 mL 1 mL 1.99 mL

*The above data is based on the productmolecular weight 1004.26. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.